For: | Messina M, Gallo E, Mella A, Pagani F, Biancone L. Update on the treatment of focal segmental glomerulosclerosis in renal transplantation. World J Transplant 2016; 6(1): 54-68 [PMID: 27011905 DOI: 10.5500/wjt.v6.i1.54] |
---|---|
URL: | https://www.wjgnet.com/2220-3230/full/v6/i1/54.htm |
Number | Citing Articles |
1 |
K.A. Alhasan, A. Alherbish, A. Osman, J.A. Kari, H. Almojalli. Successful Treatment of Recurrent Focal Segmental Glomerulosclerosis After Transplantation in Children: A Single-Center Experience. Transplantation Proceedings 2019; 51(2): 517 doi: 10.1016/j.transproceed.2019.01.004
|
2 |
Sonia Solomon, Adriana Colovai, Marcela Del Rio, Nicole Hayde. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients. Pediatric Nephrology 2020; 35(2): 261 doi: 10.1007/s00467-019-04377-6
|
3 |
Chukwuma A. Chukwu, Christopher Holmberg, Joshua Storrar, Rachel Middleton, Smeeta Sinha, Phillip A. Kalra, Howida Shawki, Anirudh Rao. Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney transplantation. Clinical Transplantation 2023; 37(6) doi: 10.1111/ctr.14970
|
4 |
Ai Katsuma, Takafumi Yamakawa, Yasuyuki Nakada, Izumi Yamamoto, Takashi Yokoo. Histopathological findings in transplanted kidneys. Renal Replacement Therapy 2017; 3(1) doi: 10.1186/s41100-016-0089-0
|
5 |
O. Staeck, F. Halleck, K. Budde, D. Khadzhynov. Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis. Transplantation Proceedings 2017; 49(10): 2256 doi: 10.1016/j.transproceed.2017.10.001
|
6 |
Lokesh Shah, David K. Hooper, Daryl Okamura, Dean Wallace, Divya Moodalbail, Caroline Gluck, Ania Koziell, Joshua J. Zaritsky. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatric Nephrology 2019; 34(11): 2343 doi: 10.1007/s00467-019-04296-6
|
7 |
Domingo Hernández, Abelardo Caballero. Kidney transplant in the next decade: Strategies, challenges and vision of the future. Nefrología (English Edition) 2023; 43(3): 281 doi: 10.1016/j.nefroe.2022.04.008
|
8 |
Natàlia Puig-Gay, Conxita Jacobs-Cacha, Joana Sellarès, Lluís Guirado, Francisco González Roncero, Carlos Jiménez, Sofía Zárraga, Javier Paul, Ricardo Lauzurica, Ángel Alonso, Ana Fernández, Isabel Beneyto, Auxiliadora Mazuecos, Domingo Hernández, Alberto Rodriguez-Benot, Antonio Franco, Luisa Jimeno, Marta Crespo, Anna Meseguer, Francesc Moreso, Daniel Seron, Joan Lopez-Hellin, Carmen Cantarell. Apolipoprotein A-Ib as a biomarker of focal segmental glomerulosclerosis recurrence after kidney transplantation: diagnostic performance and assessment of its prognostic value - a multi-centre cohort study. Transplant International 2019; 32(3): 313 doi: 10.1111/tri.13372
|
9 |
Howard Trachtman, Peter Nelson, Sharon Adler, Kirk N. Campbell, Abanti Chaudhuri, Vimal Kumar Derebail, Giovanni Gambaro, Loreto Gesualdo, Debbie S. Gipson, Jonathan Hogan, Kenneth Lieberman, Brad Marder, Kevin Edward Meyers, Esmat Mustafa, Jai Radhakrishnan, Tarak Srivastava, Miganush Stepanians, Vladimír Tesar, Olga Zhdanova, Radko Komers. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS. Journal of the American Society of Nephrology 2018; 29(11): 2745 doi: 10.1681/ASN.2018010091
|
10 |
Kalliopi Vallianou, Smaragdi Marinaki, Chrysanthi Skalioti, Sophia Lionaki, Maria Darema, Christina Melexopoulou, Ioannis Boletis. Therapeutic Options for Recurrence of Primary Focal Segmental Glomerulonephritis (FSGS) in the Renal Allograft: Single-Center Experience. Journal of Clinical Medicine 2021; 10(3): 373 doi: 10.3390/jcm10030373
|
11 |
Ryszard Grenda, Wioletta Jarmużek, Jacek Rubik, Barbara Piątosa, Sylwester Prokurat. Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome. European Journal of Pediatrics 2016; 175(9): 1133 doi: 10.1007/s00431-016-2747-1
|
12 |
Aesha Maniar, David K. Hooper, Christine B. Sethna, Pamela Singer, Avram Traum, Elizabeth Benoit, Elizabeth Kotzen, Priya Verghese, Rouba Garro, Margaret Kamel, Daniel Ranch, Weiwen Shih, Namrata G. Jain, Samhar Al‐Akash. Re‐transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study. Pediatric Transplantation 2021; 25(7) doi: 10.1111/petr.14085
|
13 |
Yong-Jin Kim. Kidney Transplantation in Sensitized Patients. 2020; : 101 doi: 10.1007/978-981-10-7046-4_8
|
14 |
Domingo Hernández, Abelardo Caballero. Trasplante renal en la próxima década: estrategias, retos y visión de futuro. Nefrología 2023; 43(3): 281 doi: 10.1016/j.nefro.2022.04.012
|
15 |
Radko Komers, Debbie S. Gipson, Peter Nelson, Sharon Adler, Tarak Srivastava, Vimal K. Derebail, Kevin E. Meyers, Pablo Pergola, Meghan E. MacNally, Jennifer L. Hunt, Alvin Shih, Howard Trachtman. Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET). Kidney International Reports 2017; 2(4): 654 doi: 10.1016/j.ekir.2017.02.019
|
16 |
H. Pinto, R. Leal, L. Rodrigues, L. Santos, C. Romãozinho, F. Macário, R. Alves, J. Pratas, V. Sousa, C. Marinho, L. Prado e Castro, F. Costa, M. Campos, A. Mota, A. Figueiredo. What Can We Do When All Collapses? Fatal Outcome of Collapsing Glomerulopathy and Systemic Lupus Erythematosus With Diffuse Alveolar Hemorrhage: Case Report. Transplantation Proceedings 2017; 49(4): 913 doi: 10.1016/j.transproceed.2017.03.007
|
17 |
Ben C. Reynolds, Angela Lamb, Caroline A. Jones, Pallavi Yadav, Kay S. Tyerman, Colin C. Geddes. UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology 2022; 37(1): 199 doi: 10.1007/s00467-021-05248-9
|
18 |
Marci English, Emily Hawryluk, Robert Krupnick, Mysore S. A. Kumar, Jason Schwartz. The Symptoms and Impact of Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Conceptual Model of the Patient Experience. Advances in Therapy 2019; 36(12): 3390 doi: 10.1007/s12325-019-01110-5
|